Microsatellite alterations in serum DNA of head and neck cancer patients

Nature Medicine

Volumn 2, Issue 9, 1996, Pages 1035-1037

  Nawroz, Homaira ^a   Koch, Wayne ^a   Anker, Philippe ^b   Stroun, Maurice ^b   Sidransky, David ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

SATELLITE DNA;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CANCER DIAGNOSIS; CLINICAL ARTICLE; FEMALE; HEAD AND NECK CANCER; HUMAN; MALE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; DNA PRIMERS; DNA, NEOPLASM; DNA, SATELLITE; FEMALE; GENE DELETION; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; TUMOR MARKERS, BIOLOGICAL;

EID: 0029836445     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0996-1035     Document Type: Article

References (20)

1. Mao, L. et al. Molecular detection of primary bladder cancer by microsatellite analysis. Science 271, 659-662 (1996)
2. Mao, L et al. Microsatellite alterations as clonal markers for the detection of human cancer. Proc. Natl. Acad Sci. USA 91, 9871-9875 (1994).
3. Merlo, A. et al. Frequent microsatellite instability in primary small cell lung cancer Cancer Res. 54, 2098-2101 (1994).
4. Stroun, M et al. Neoplastic characteristics of the DNA found in the plasma of cancer patients. Oncology 46, 318-322 (1989).
5. Stroun, M., Anker, P., Lyautey, J., Lederrey, C & Maurice, P Isolation and characterization of DNA from the plasma of cancer patients. Eur J Clin. Oncol. 23, 707-712 (1987).
6. Nawroz, H. et al. Allelotype of head and neck squamous cell carcinoma Cancer Res 54, 1152-1155 (1994)
7. Califano, J et al. A genetic progression model for head and neck cancer: Implications for field cancerization Cancer Res. 56, 2488-2492 (1996).
8. Shapiro, B., et al. Determination of circulating DNA levels in patients with benign or malignant gastrointestinal disease Cancer 51, 2116-2120 (1983).
9. Leon, S.A. et al. Free DNA in the serum of cancer patients and the effect of therapy Cancer Res. 37, 646-650 (1977)
10. Vasioukhin, V. et al. Point mutations of the N-ras gene in the blood plasma DNA of patients with myelodysplastic syndrome or acute myelogenous leukaemia Br. J. Haematol 86, 774-779 (1994).
11. Vasioukhin, V et al K-ras point mutations in the blood plasma DNA of patients with colorectal tumors in Challenges of Modern Medicine Biotechnology Today, (eds Verna, R & Shamoo, A.) 141-150 (Ares-Serano Symposia Publications, Rome, 1994)
12. Sorenson, G D et al. Soluble normal and mutated DNA sequences from single-copy genes in human blood. Cancer Epidemiol. Biomark. Prev. 3, 67-71 (1994)
13. Chen, X Q et al. Microsatellite alterations in plasma DNA of small cell lung cancer patients Nature Med 2, 1034-1036 (1996)
14. Vokes, E E., Weichselbaum, R R, Lippman, S M & Hong, W K Head and neck cancer [review] N. Engl. J Med. 328, 184-194 (1993)
15. Brennan, J. et al. Molecular assessment of histopathological staging in squamous cell carcinoma of the head and neck N. Engl J. Med 332, 429-435 (1995)
16. Boyle, J.O et al. The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res. 53, 4477-4480 (1993).
17. Van der Riet, P et al. Progression of basal cell carcinoma through loss of chromosome 9q and inactivation of single p53 allele. Cancer Res. 54, 25-27 (1994)
18. Sidransky, D. et al. Identification of p53 gene mutations in bladder cancers and urine samples. Science 252, 706-709 (1991).
19. Litt, M., Hauge, X & Sharma, V. Shadow bands seen when typing polymorphic dinucleotide repeats Some causes and cures Biotechniques 15, 280-284 (1993)
20. Beahrs, O , Henson, D , Hutter, R & Myers, M eds. Manual for Staging of Cancer. 3rd edn 27-62 (Lippincott, Philadelphia, 1988).